David A. Reis Sells 47,755 Shares of Genesis Healthcare Inc (GEN) Stock

Share on StockTwits

Genesis Healthcare Inc (NYSE:GEN) Director David A. Reis sold 47,755 shares of Genesis Healthcare stock in a transaction dated Tuesday, September 4th. The shares were sold at an average price of $1.74, for a total transaction of $83,093.70. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

David A. Reis also recently made the following trade(s):

  • On Thursday, August 30th, David A. Reis sold 44,975 shares of Genesis Healthcare stock. The shares were sold at an average price of $1.74, for a total transaction of $78,256.50.
  • On Tuesday, August 28th, David A. Reis sold 64,064 shares of Genesis Healthcare stock. The shares were sold at an average price of $1.72, for a total transaction of $110,190.08.
  • On Friday, August 24th, David A. Reis sold 71,070 shares of Genesis Healthcare stock. The shares were sold at an average price of $1.70, for a total transaction of $120,819.00.
  • On Tuesday, August 14th, David A. Reis sold 47,365 shares of Genesis Healthcare stock. The stock was sold at an average price of $1.65, for a total transaction of $78,152.25.
  • On Thursday, August 9th, David A. Reis sold 101,404 shares of Genesis Healthcare stock. The stock was sold at an average price of $1.69, for a total transaction of $171,372.76.

NYSE:GEN opened at $1.51 on Friday. Genesis Healthcare Inc has a one year low of $0.60 and a one year high of $2.86. The company has a debt-to-equity ratio of -2.61, a quick ratio of 1.03 and a current ratio of 1.03. The stock has a market cap of $242.30 million, a P/E ratio of -0.72 and a beta of 0.70.

Genesis Healthcare (NYSE:GEN) last posted its quarterly earnings data on Tuesday, August 7th. The company reported ($0.39) EPS for the quarter, missing the consensus estimate of ($0.26) by ($0.13). The company had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.31 billion. During the same quarter in the prior year, the firm earned ($0.70) earnings per share. research analysts anticipate that Genesis Healthcare Inc will post -1.26 EPS for the current fiscal year.

Several equities research analysts recently commented on GEN shares. ValuEngine raised shares of Genesis Healthcare from a “hold” rating to a “buy” rating in a research note on Tuesday. Cantor Fitzgerald reissued a “buy” rating and set a $7.00 price objective on shares of Genesis Healthcare in a research note on Tuesday, August 7th. Three analysts have rated the stock with a hold rating and two have given a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $3.25.

A number of institutional investors have recently modified their holdings of GEN. Renaissance Technologies LLC raised its holdings in Genesis Healthcare by 55.3% in the second quarter. Renaissance Technologies LLC now owns 2,424,200 shares of the company’s stock worth $5,551,000 after buying an additional 863,600 shares during the last quarter. BlackRock Inc. raised its holdings in Genesis Healthcare by 37.2% in the second quarter. BlackRock Inc. now owns 3,158,317 shares of the company’s stock worth $7,233,000 after buying an additional 855,900 shares during the last quarter. Acadian Asset Management LLC raised its holdings in Genesis Healthcare by 715.9% in the second quarter. Acadian Asset Management LLC now owns 813,222 shares of the company’s stock worth $1,862,000 after buying an additional 713,545 shares during the last quarter. EAM Investors LLC purchased a new position in Genesis Healthcare in the second quarter worth about $783,000. Finally, V3 Capital Management L.P. raised its holdings in Genesis Healthcare by 12.5% in the first quarter. V3 Capital Management L.P. now owns 2,544,608 shares of the company’s stock worth $3,842,000 after buying an additional 282,709 shares during the last quarter. 19.72% of the stock is owned by institutional investors and hedge funds.

Genesis Healthcare Company Profile

Genesis Healthcare, Inc, together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy.

Read More: Discover Your Risk Tolerance

Insider Buying and Selling by Quarter for Genesis Healthcare (NYSE:GEN)

Receive News & Ratings for Genesis Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply